ProgenityLogo.jpg
Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
January 03, 2022 06:30 ET | Progenity, Inc.
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
ProgenityLogo.jpg
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
December 20, 2021 16:05 ET | Progenity, Inc.
SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
ProgenityLogo.jpg
Progenity Strengthens its Liquidity Position
November 23, 2021 06:30 ET | Progenity, Inc.
Company received more than $44 million in warrant exercises since August 2021. Current liquidity position provides runway to achieve critical research and development milestones through 2022. SAN...
ProgenityLogo.jpg
Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 15, 2021 06:30 ET | Progenity, Inc.
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at...
ProgenityLogo.jpg
Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results
November 10, 2021 16:01 ET | Progenity, Inc.
Added important patents further protecting the company’s therapeutic delivery technologiesAdded strong biotherapeutics capabilities to management team and board of directorsImplemented cost-cutting...
ProgenityLogo.jpg
Progenity Appoints Adi Mohanty as Chief Executive Officer
November 09, 2021 06:30 ET | Progenity, Inc.
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Adi Mohanty as Chief Executive Officer of the...